This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jan;105(1):134-5.

doi: 10.1111/j.1360-0443.2009.02824.x.

Commentary on Morgan et al. (2010): ketamine abuse: first medical evidence of harms we should confront

Rafael De La Torre¹

Affiliations

Affiliation

¹ IMIM-Hospital del Mar-Human Pharmacology and Clinical Neurosciences Research Group, Neuropsychopharmacology Research Programme, Barcelona, Spain. rtorre@imim.es

PMID: 20078466
DOI: 10.1111/j.1360-0443.2009.02824.x

Comment

Commentary on Morgan et al. (2010): ketamine abuse: first medical evidence of harms we should confront

Rafael De La Torre. Addiction. 2010 Jan.

. 2010 Jan;105(1):134-5.

doi: 10.1111/j.1360-0443.2009.02824.x.

Author

Rafael De La Torre¹

Affiliation

¹ IMIM-Hospital del Mar-Human Pharmacology and Clinical Neurosciences Research Group, Neuropsychopharmacology Research Programme, Barcelona, Spain. rtorre@imim.es

PMID: 20078466
DOI: 10.1111/j.1360-0443.2009.02824.x

No abstract available

PubMed Disclaimer

Comment on

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
Morgan CJ, Muetzelfeldt L, Curran HV. Morgan CJ, et al. Addiction. 2010 Jan;105(1):121-33. doi: 10.1111/j.1360-0443.2009.02761.x. Epub 2009 Nov 17. Addiction. 2010. PMID: 19919593

Similar articles

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
Morgan CJ, Muetzelfeldt L, Curran HV. Morgan CJ, et al. Addiction. 2010 Jan;105(1):121-33. doi: 10.1111/j.1360-0443.2009.02761.x. Epub 2009 Nov 17. Addiction. 2010. PMID: 19919593
[Urinary tract lesions associated to ketamine consumption].
García-Larrosa A, Capdevila S, Laborda A, Vargas C. García-Larrosa A, et al. Med Clin (Barc). 2014 Oct 21;143(8):372-3. doi: 10.1016/j.medcli.2013.11.019. Epub 2014 Jan 22. Med Clin (Barc). 2014. PMID: 24461740 Spanish. No abstract available.
Ketamine cystitis: an emerging diagnostic and therapeutic challenge.
Gray T, Dass M. Gray T, et al. Br J Hosp Med (Lond). 2012 Oct;73(10):576-9. doi: 10.12968/hmed.2012.73.10.576. Br J Hosp Med (Lond). 2012. PMID: 23124288 Review.
Ketamine-induced vesicopathy: a literature review.
Middela S, Pearce I. Middela S, et al. Int J Clin Pract. 2011 Jan;65(1):27-30. doi: 10.1111/j.1742-1241.2010.02502.x. Int J Clin Pract. 2011. PMID: 21155941 Review.
[Ketamine as a party drug].
Vroegop MP, van Dongen RT, Vantroyen B, Kramers C. Vroegop MP, et al. Ned Tijdschr Geneeskd. 2007 Sep 15;151(37):2039-42. Ned Tijdschr Geneeskd. 2007. PMID: 17929712 Review. Dutch.

See all similar articles

Cited by

Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Kokane SS, Armant RJ, Bolaños-Guzmán CA, Perrotti LI. Kokane SS, et al. Behav Brain Res. 2020 Apr 20;384:112548. doi: 10.1016/j.bbr.2020.112548. Epub 2020 Feb 13. Behav Brain Res. 2020. PMID: 32061748 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information